Your account is not claimed yet. You can sign up with ORCID to claim your account.

Amir Ghaemi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 18

Top Venues

Cancer cell international

Virology journal

Nutrients

Future oncology (London, England)

Pasteur Institute of Iran,

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pasteur Institute of Iran,

Iran

Associate Professor :: Virology

Publications

Zahra Saeedirad, Shadi Ariyanfar, Morvarid Noormohammadi, Zeinab Ghorbani, Abdorreza Naser Moghadasi, Sahar Shahemi, Milad Ghanaatgar, Nasim Rezaeimanesh, Azita Hekmatdoost, Amir Ghaemi, Soodeh Razeghi Jahromi
Higher Dietary Acid Load Might Be a Potent Derivative Factor for Multiple Sclerosis: The Results from a Case-Control Study. Nutrients 15 (15) (2023)
Mahmoud Ganji, Shohreh Bakhshi, Khadijeh Ahmadi, Alireza Shoari, Soheila Moeini, Amir Ghaemi
Rational design of B-cell and T-cell multi epitope-based vaccine against Zika virus, an in silico study. Journal of biomolecular structure & dynamics (2023)
Mehdi Samadi, Vahid Salimi, Mohammad Reza Haghshenas, Seyed Mohammad Miri, Seyed Reza Mohebbi, Amir Ghaemi
Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent. Virology journal 19 (1) (2022)
Seyed Mohammad Miri, Behzad Pourhossein, Seyed Younes Hosseini, Mohsen Keshavarz, Shohreh Shahmahmoodi, Mohammad Reza Zolfaghari, Seyed Reza Mohebbi, Ali Gorji, Amir Ghaemi
Enhanced synergistic antitumor effect of a DNA vaccine with anticancer cytokine, MDA-7/IL-24, and immune checkpoint blockade. Virology journal 19 (1) (2022)
Fatemeh Samiee, Reza Mohammadi, Sadegh Shirian, Mohammad-Reza Alijani, Azita Aledavood, Shahrzad Negahban, Amir Ghaemi, Khosrow Daneshbod, Yahya Daneshbod
Spectrum of lymphoma subtypes based on the latest World Health Organization classification in southern Iran from 2000 to 2011. Future oncology (London, England) 17 (34) (2021)
Samaneh Rostaminia, Seyed Soheil Aghaei, Behrokh Farahmand, Raziye Nazari, Amir Ghaemi
Computational Design and Analysis of a Multi-epitope Against Influenza A virus. International journal of peptide research and therapeutics (2021)
Ailar Sabbaghi, Masoud Malek, Sara Abdolahi, Seyed Mohammad Miri, Leila Alizadeh, Mehdi Samadi, Seyed Reza Mohebbi, Amir Ghaemi
Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine. Virology journal 18 (1) (2021)
Ailar Sabbaghi, Masoud Malek, Sara Abdolahi, Seyed Mohammad Miri, Leila Alizadeh, Mehdi Samadi, Seyed Reza Mohebbi, Amir Ghaemi
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine. Virology journal 18 (1) (2021)
Ailar Sabbaghi, Mohsen Zargar, Mohammad Reza Zolfaghari, Farahnaz Motamedi-Sedeh, Amir Ghaemi
Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model. Archives of virology 166 (2) (2021)
Seyed Mohammad Miri, Elham Tafsiri, William Chi Shing Cho, Amir Ghaemi
Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy. Cancer cell international 20 (1) (2020)
Seyed Mohammad Miri, Farshid Noorbakhsh, Seyed Reza Mohebbi, Amir Ghaemi
Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues. Journal of medical virology 92 (11) (2020)
Seyed Mohammad Miri, Mir Saeed Ebrahimzadeh, Elahe Abdolalipour, Mahsa Yazdi, Hassan Hosseini Ravandi, Amir Ghaemi
Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade. Cancer cell international 20 (2020)
Seyed Mohammad Miri, Elham Tafsiri, William Chi Shing Cho, Amir Ghaemi
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy. Cancer cell international 20 (2020)
Seyed Mohammad Miri, Mir Saeed Ebrahimzadeh, Elahe Abdolalipour, Mahsa Yazdi, Hassan Hosseini Ravandi, Amir Ghaemi
Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade. Cancer cell international 20 (1) (2020)
Ailar Sabbaghi, Seyed Mohammad Miri, Mohsen Keshavarz, Mehran Mahooti, Arghavan Zebardast, Amir Ghaemi
Role of γδ T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches. Virology journal 17 (1) (2020)
Seyed Mohammad Miri, Elham Tafsiri, William Chi Shing Cho, Amir Ghaemi
Correction to: CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy. Cancer cell international 20 (2020)
Seyed Mohammad Miri, Mir Saeed Ebrahimzadeh, Elahe Abdolalipour, Mahsa Yazdi, Hassan Hosseini Ravandi, Amir Ghaemi
Correction to: Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade. Cancer cell international 20 (2020)
Ailar Sabbaghi, Seyed Mohammad Miri, Mohsen Keshavarz, Mohsen Zargar, Amir Ghaemi
Inactivation methods for whole influenza vaccine production. Reviews in medical virology 29 (6) (2019)

Amir Ghaemi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Amir Ghaemi